Equity Awards and Warrants - Private Placement of Shares of Common Stock and Warrants (Details)
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
Feb. 13, 2023
USD ($)
$ / shares
shares
|
Jan. 12, 2023
$ / shares
|
Aug. 31, 2022
USD ($)
$ / shares
shares
|
Aug. 30, 2022
$ / shares
shares
|
Aug. 02, 2022
shares
|
Mar. 25, 2022
shares
|
Feb. 14, 2022
shares
|
Feb. 04, 2022
shares
|
May 31, 2021
USD ($)
$ / shares
shares
|
Mar. 31, 2023
USD ($)
$ / shares
shares
|
Jan. 31, 2023
USD ($)
$ / shares
shares
|
Nov. 30, 2022
USD ($)
$ / shares
shares
|
Jul. 31, 2022
shares
|
Jun. 30, 2022
USD ($)
$ / shares
shares
|
Apr. 30, 2022
shares
|
Feb. 28, 2022
USD ($)
$ / shares
shares
|
Mar. 31, 2023
USD ($)
$ / shares
shares
|
Feb. 28, 2023
USD ($)
$ / shares
shares
|
Aug. 31, 2022
USD ($)
$ / shares
shares
|
Jun. 30, 2022
USD ($)
$ / shares
shares
|
Feb. 28, 2022
USD ($)
$ / shares
shares
|
Nov. 30, 2021
USD ($)
|
[1] |
Aug. 31, 2021
USD ($)
|
[1] |
Feb. 28, 2023
USD ($)
$ / shares
shares
|
Feb. 28, 2022
USD ($)
$ / shares
shares
|
May 31, 2022
USD ($)
item
$ / shares
shares
|
May 31, 2021
USD ($)
$ / shares
shares
|
Mar. 10, 2023
USD ($)
|
Jan. 05, 2023
USD ($)
|
Dec. 31, 2022
$ / shares
shares
|
Jul. 08, 2022
shares
|
Jul. 07, 2022
shares
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercises (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,400,000
|
26,700,000
|
|
|
|
|
|
Exercise of warrants for cash | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
$ 1,000,000.0
|
|
|
|
|
|
|
Exercise of warrants for cash, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
200,000
|
|
|
|
|
|
|
Cashless exercise of warrants, warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
300,000
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
400,000
|
|
4,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
7,900,000
|
|
|
|
|
|
|
Finance charges related to warrant issuance for surety bond backstop agreement | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,885,000
|
$ 8,601,000
|
|
$ 6,585,000
|
[1] |
|
|
|
|
|
$ 6,585,000
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
5,500,000
|
|
|
|
|
|
|
71,100,000
|
|
|
|
|
|
|
71,100,000
|
|
5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
5 years
|
10 years
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number Of Warrants In fixed Combination Issue Of Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.3
|
|
|
|
|
|
|
Warrant covering common stock shares purchased, percentage |
|
|
75.00%
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
|
|
Placement agent fees and expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000.0
|
|
|
$ 2,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,045,000
|
|
|
$ 3,552,000
|
[1] |
|
|
|
|
|
$ 46,511,000
|
$ 1,000,000
|
|
|
|
|
|
Incremental fair value of warrants | $ |
|
|
$ 4,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of warrants expiration extended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,800,000
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 264,000
|
$ 1,036,000
|
[1] |
$ 1,036,000
|
$ 19,428,000
|
|
|
|
|
|
Deemed dividends | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares Authorized |
|
|
1,350,000,000
|
1,000,000,000.0
|
|
|
|
|
1,350,000,000
|
|
|
|
|
|
|
|
|
1,350,000,000
|
1,350,000,000
|
|
|
|
|
|
1,350,000,000
|
|
|
1,350,000,000
|
1,350,000,000
|
|
|
|
|
|
CytoDyn Inc. | David F Welch |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ownership percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
|
|
|
Back Stop Warrant #1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.10
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500,000
|
|
|
Back Stop Warrant #2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.10
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500,000
|
|
|
|
|
|
|
7,500,000
|
|
|
|
|
|
|
7,500,000
|
|
|
Former CEO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation policy period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 months
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
908,418
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
380,704
|
|
|
|
|
|
|
|
|
|
Former General Counsel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation policy period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 months
|
|
|
|
|
|
|
Severance payment | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 12,500
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79,391
|
|
|
155,612
|
|
|
|
|
|
|
Executives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of salary in lieu of cash, net of payroll deductions and withholding taxes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
522,382
|
|
|
|
|
|
|
|
|
|
|
|
|
317,441
|
|
|
|
|
|
|
Private Equity Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,900,000
|
|
|
|
|
|
Stock based compensation | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
Number of common shares in a fixed combination issue of shares |
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
Number Of Warrants In fixed Combination Issue Of Securities |
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,544,000
|
|
|
|
$ 27,307,000
|
$ 2,872,000
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 23,600,000
|
|
|
|
|
|
Private Equity Offering | Consultant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.04
|
|
|
|
|
$ 1.04
|
|
|
|
|
$ 1.04
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
25,000
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
Private Equity Offering | Placement Agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.40
|
|
|
|
|
|
|
Warrant exercises (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,400,000
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38,100,000
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,600,000
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 years
|
|
|
|
|
|
|
Non-cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,700,000
|
|
|
|
|
|
|
Cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
|
|
Accredited Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercises (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,300,000
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
4,100,000
|
|
|
|
|
|
|
|
|
|
|
85,400,000
|
|
|
|
|
|
|
|
34,600,000
|
8,800,000
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
900,000
|
71.1
|
|
|
|
|
|
|
71.1
|
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
|
|
|
|
Non-cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,200,000
|
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,400,000
|
|
|
$ 18,900,000
|
|
|
|
|
|
|
|
$ 5,400,000
|
|
|
|
|
|
|
Proceeds, net of issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,300,000
|
|
|
$ 7,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Warrant Exchange [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exchanged (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,500,000
|
32,600,000
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
36,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,800,000
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,900,000
|
|
|
|
|
|
|
Non-cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,000,000.0
|
|
|
|
|
|
Placement agent fees and expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
$ 34,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of warrants, net of offering costs (in shares) |
|
|
|
|
|
|
|
|
|
|
|
9,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued on warrant inducement |
|
|
|
|
|
|
|
|
|
|
|
8,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividends | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Warrant Exchange [Member] | Cyrus Arman |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
$ 0.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares per warrant |
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from Issuance of Common Stock | $ |
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares per unit |
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Warrant Exchange [Member] | Placement Agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,700,000
|
$ 13,900,000
|
|
|
|
|
|
Private Warrant Exchange, Non-Inducement Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash inducement interest expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
Allotment to placement agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
$ 0.40
|
|
|
|
|
|
|
$ 0.23
|
|
|
$ 0.255
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
|
Increase in number of shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350,000,000
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
10,700,000
|
|
|
19,400,000
|
|
|
|
|
|
19,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
Warrant covering common stock shares purchased, percentage |
|
|
|
|
|
|
|
|
|
|
15.00%
|
|
|
|
|
|
12.00%
|
|
|
13.00%
|
|
|
|
|
|
|
|
13.00%
|
|
|
|
|
|
|
Placement agent fees and expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
Allotment to placement agent | Placement Agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,400,000
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
Warrant covering common stock shares purchased, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.00%
|
|
|
|
|
|
|
Second Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.306
|
|
|
|
|
|
$ 0.306
|
|
|
|
|
|
|
|
$ 0.30
|
|
|
|
|
|
|
Exercise price of stock warrant combo, per share | $ / shares |
|
$ 0.23
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65.6
|
|
|
|
|
|
|
|
|
|
|
34,600,000
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
64,000,000.0
|
|
|
|
|
|
64,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
Number of common shares in a fixed combination issue of shares |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
1
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Number Of Warrants In fixed Combination Issue Of Securities |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
1
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Warrant exercise price percentage of final unit price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120.00%
|
|
|
|
|
|
|
|
120.00%
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,800,000
|
|
|
|
|
|
|
Closing share price (as percentage) |
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Subscription Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
Number of private placements conducted | item |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,400,000
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000.0
|
|
|
|
|
|
|
Number of common shares in a fixed combination issue of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
Placement agent fees and expenses | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
Proceeds from Issuance of Common Stock | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,400,000
|
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000.0
|
|
|
|
|
|
|
Surety Bond Backstop Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock based compensation | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,600,000
|
|
|
|
|
|
|
Finance charges related to warrant issuance for surety bond backstop agreement | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,900,000
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000
|
|
|
|
|
|
|
Interest rate |
|
|
|
|
|
|
10.00%
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period of Indemnification, Payment by Indemnitors |
|
|
|
|
|
|
90 days
|
90 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indemnification Fee Payment Ratio |
|
|
|
|
|
|
1.50%
|
1.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of cash collateral to be relieved of amount currently pledged | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,100,000
|
|
|
|
|
|
|
5,100,000
|
|
|
|
|
|
|
|
|
|
Amount of cash collateral to be relieved of amount currently pledged by Indemnity in support of Surety Bond | $ |
|
|
|
|
|
|
|
|
|
|
$ 5,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Cash | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,100,000
|
|
|
|
|
|
|
$ 5,100,000
|
|
|
|
|
|
|
|
|
|
Surety Bond Backstop Agreement | Four Good Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.10
|
|
|
|
|
|
|
$ 0.10
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
Initial Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
15,000,000.0
|
15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Make-Whole Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
15,000,000.0
|
15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Four Good Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.20
|
|
|
|
|
|
|
Finance charges related to warrant issuance for surety bond backstop agreement | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,600,000
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercises (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued on warrant inducement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercises | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Cash | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
$ 0.255
|
|
|
|
|
|
$ 1.00
|
|
|
|
|
|
|
|
|
$ 0.75
|
$ 0.255
|
|
|
|
|
|
$ 0.75
|
|
|
$ 1.35
|
$ 1.00
|
|
|
|
|
|
Cashless exercise of warrants, exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.50
|
|
|
|
|
|
|
0.50
|
|
|
0.83
|
|
|
|
|
|
|
Maximum | Private Equity Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
1.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.80
|
|
|
|
|
|
Maximum | Accredited Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00
|
1.00
|
|
|
|
|
|
Maximum | Private Warrant Exchange [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.90
|
|
|
|
|
|
Warrants grant date fair value | $ / shares |
|
|
|
|
|
|
|
|
1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.50
|
|
|
|
|
|
Maximum | Allotment to placement agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
$ 0.306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.306
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum | Four Good Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.30
|
|
|
|
|
|
|
Maximum | Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.75
|
|
|
|
|
|
|
0.75
|
|
|
|
|
|
|
|
|
|
Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
0.45
|
|
|
|
|
|
|
|
|
0.45
|
|
|
|
|
|
|
0.45
|
|
|
0.45
|
0.45
|
|
|
|
|
|
Cashless exercise of warrants, exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.26
|
|
|
|
|
|
|
0.26
|
|
|
0.40
|
|
|
|
|
|
|
Warrant covering common stock shares purchased, percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.40%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum | Private Equity Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
0.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.40
|
|
|
|
|
|
Minimum | Accredited Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
0.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.45
|
0.40
|
|
|
|
|
|
Minimum | Private Warrant Exchange [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
0.21
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.21
|
|
|
|
|
|
Warrants grant date fair value | $ / shares |
|
|
|
|
|
|
|
|
$ 0.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.30
|
|
|
|
|
|
Minimum | Surety Bond Backstop Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of cash collateral to be relieved of amount currently pledged | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
Minimum | Warrant Exchange Agreements [Member] | Accredited Investors Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
|
|
|
Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for private offerings | $ |
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares Authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,350,000,000
|
1,000,000,000
|
Subsequent Event | Former CEO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
69,040
|
|
|
|
|
|
|
|
26,106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent Event | Private Equity Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.30
|
|
|
|
|
|
$ 0.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of stock warrant combo, per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
$ 0.255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued during the period new issues shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
50,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.75
|
|
|
|
|
|
0.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price percentage of final unit price |
|
|
|
|
|
|
|
|
|
|
|
|
|
120.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds, net of issuance costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent Event | Private Equity Offering | Placement Agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of share | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock warrants to purchase shares |
|
|
|
|
|
|
|
|
|
5,500,000
|
|
|
|
|
|
|
5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares per warrant |
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of warrants |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds, net of issuance costs | $ |
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares per unit |
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent Event | Surety Bond Backstop Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of cash collateral to be relieved of amount currently pledged | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
|
|
|
|
|
|